CHEST Physician
-
GLP-1RAs may trigger chronic cough for some patients with diabetes
Surprisingly, the association between GLP-1 medications and chronic cough was stronger in patients without an existing diagnosis of gastroesophageal reflux disease.
-
Optimal synergy: Coupling smart wearable devices, sensors with AI algorithms
Coupling noninvasive wearable devices with AI-enabled data analytics helps to address two key challenges: health care access and improvement of patient-centric care.
-
De-escalating antibiotics proves safe for patients with community-onset sepsis
Ashwin B. Gupta, MD, addresses lingering clinician hesitancy surrounding the de-escalation of antibiotics for adults hospitalized for community-onset sepsis.
-
GLP-1RAs may reduce risk of asthma exacerbations for adolescents with obesity
Pulmonologist Farrukh Abbas, MD, said this observational study generates a hypothesis about the anti-inflammatory benefits of GLP1-RA medications in patients with asthma and obesity that needs to be confirmed in trials.
-
Bridging the gap: Mechanical circulatory support in lung transplantation for PAH
Review the need for ECLS, MCS, and ECMO in patients with PAH who are undergoing lung transplantation.
-
GOLD 2026 updates in global strategy for diagnosis, management, and prevention of COPD
The GOLD 2026 report advances a contemporary model of COPD as a modifiable, biologically active disease requiring individualized and proactive management.
-
New statement proposes updated ILD classification, introduces new terminology
A new consensus statement from the American Thoracic Society and the European Respiratory Journal introduces ILD terminology such as bronchiolocentric interstitial pneumonia and alveolar macrophage pneumonia.
-
Definitions matter: How should we define diagnostic yield in bronchoscopy?
A recent consensus statement from CHEST and the American Thoracic Society proposes a strict diagnostic yield definition, reiterating the need for close follow-up in patients with nonspecific benign findings.
-
2026 GOLD report provides key updates on COPD exacerbations, case finding
Gerard J. Criner, MD, FCCP, a member of the GOLD Science Committee, said the latest insights aim to improve patient outcomes and bring awareness to treating COPD exacerbations.
-
AI-enabled approaches poised to transform diagnosis, management of lung diseases
Experts explore how AI-based tools can be used to bridge diagnostic challenges and address unmet needs in chronic respiratory disease care.
